Excessive production of viscous mucus in the airway is a characteristic feature in chronic obstructive pulmonary diseases. The overproduced viscous mucus causes an inhibition of the function of the airway clearing system and thereby becomes the cause of obstruction and infection of the respiratory tract. In the treatment of these symptoms, expectorants have been widely used to prompt the expelling of the mucus plug.
It is known that bromhexine. N-(2-amino-3,5-di bromobenzyl) -N -cyclohexyl -methyl amine, is an efficient expectorant possessing both secretagogic action of respiratory tract fluid (RTF) (1-4) and mucolytic action on respiratory mucus (1, 5, 6) . The mechanism for the expectorant action of bromhexine, however, has not been well understood. It was found that the secretagogic action of bromhexine results from a selective promotion of the secretory activity of submucosal glands in the lamina propria mucosae of the respiratory tract and that the mucolytic action of the agent results from a dissolution of acid glycoprotein (AGP), a chief viscous factor (7, 8) , contained in mucus granules of both goblet cells in the epithelium and submucosal glandular cells (9-1 1 ). In a previous paper, we reported an in vitro result that the et al. The analytical method for photomicrographs of submucosal glands in the tracheal tissues were described previously (9) (10) (11) (13) (14) (15) (16) (17) (18) . In this study, the ratio of acinar inner diameter of submucosal gland to the tracheal wall thickness (AMR) was used to represent the histological parameters. The wall thickness means the tissue thickness between the basement membrane of the epithelium and the inner side of the cartilage. As a histochemical parameter, the color (stain index) of the glandular cell in the AB (pH 2.5)/PAS procedure was used.
Results
Time course of bromhexine-induced changes in tracheal submucosal glands: Changes in A'WR of submucosal glands following bromhexine treatment are shown in Fig. 1 . The precontrol A'WR level was 0.050±0.002 (mean±S.E., N=19). In the control group, AiWR remained much the same throughout a 6-hr observation period. On the other hand, when bromhexine was given at 10 or 20 mg/kg, AiWR significantly increased biphasically; one peak was observed at 0.5 hr after drug administration, and the other A'WR increase was after 2 to 6 hr. In the 5 mg/kg group, a similar pattern was obtained, although the changes were small. 447 In Fig. 2 Fig. 1 . lysosomal enzymes into the cytoplasm, and the enzymes liberated would then exert a mucolytic action on AGP contained in mucus granules of airway secretory cells (11) . In the present study where bromhexine was administered into the stomach, AiWR markedly increased after 0.5 hr, followed by a decrease after 1 hr, and it significantly increased again after 2 to 6 hr. These histological findings suggest that the in vivo secretagogic action of bromhexine on submucosal glands occurs biphasically: the first being a transient phase and the second, a prolonged phase.
Engelhorn and Puschmann (1) reported that the increased volume of RTF in rabbits after administration of bromhexine in a dose of 2 mg/kg into the stomach was not reduced by 1 mg/kg atropine sufficiently to block cholinergic effects. Also, Boyd and Sheppard (2) showed that the increase in RTF output produced by bromhexine (5 mg/kg into the stomach) in rabbits was not affected by atropine in doses of 20 and 40 mg/kg s.c., although atopine in toxic doses (60 and 80 mg/kg s.c.) almost abolished the response. They concluded that bromhexine would increase RTF output through a direct action on airway tissue and not through a vagal reflex or any cholinergic nervous mechanisms.
In the present study, emetine, presumably a reflexive secretagogue (19, 20) , produced a marked increase in AIWR at 0.5 hr after administration into the stomach, followed by a decrease. The emetine-induced changes in AM/R were inhibited by atropine or bilateral cervical vagotomy. This result suggests that the secretagogic action of emetine on submucosal glands may be chiefly caused by the vagal reflex through a gastrointestinal irritation. The decrease in AIWR seen after 1 to 2 hr might occur as a rebound from the preceding increase in AIWR. Similarly, the bromhexine-induced early increase in AIWR seen after 0.5 hr was also inhibited by atropine in a dose usually used for cholinergic blockade or by surgical vagotomy, indicating that in this secretagogic phase, the vagal reflex from the gastric mucosa may be involved. The second secretagogic phase seen during 2 to 6 hr after bromhexine treatment was not, however, influenced by either cholinergic blockade. These findings strongly suggest that bromhexine works through both mechanisms: a vagal reflex from the gastric mucosa and a direct stimulant action on submucosal glands. In the studies of Engelhorn and Puschmann (1) and Boyd and Sheppard (2) described above, they might have been unable to detect the early secretagogic action of bromhexine through the vagal reflex because in their experiments, RTF volumes were measured at every 2 hr after administration.
After bromhexine treatment, the number of submucosal glandular cells showing a stain index B &P was markedly decreased, while the number of cells showing a stain index R was increased. These histochemical changes appeared strongly 1 to 6 hr after drug administration. These findings suggest that bromhexine may dissolve high molecular weight AGP in granules of glandular cells through a mucolytic action because AB colors blue only when a single dye molecule combines with several polyanion sites on one AGP molecule (21, 22) . Furthermore, the time course of the histochemical changes suggests that there is a lag time before onset of the strong mucolytic action of bromhexine. The reason why it takes time for the agent to produce intense mucolysis in contrast to its secretagogic action seems to be that the mucolytic action of bromhexine is induced enzymatically through a liberation of lysosomal enzymes in the tracheal tissue. That is, the mucolytic action is considered to be elicited through a direct action on the tracheal tissue, so a sufficient plasma concentration has to be attained after intragastric administration. This may be supported by the finding that the histochemical changes were not influenced by cholinergic blockade. The degrees of histological and histochemical changes observed in this in vivo study using [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] mg/kg of bromhexine roughly resembled those observed in the in vitro study using 10-6-10-5 M/l of bromhexine.
In conclusion, the secretagogic action of bromhexine on submucosal glands occurs biphasically; the first phase results from the vagal reflex probably through a gastrointestinal irritation, and the second phase results from a direct action on the glands.
